Abstract
Recent years have seen the emergence of new influenza A strains with high mortality. Oseltamivir, when given early after symptom onset, has been shown to improve survival. Some authorities believe that raising the dose might increase efficacy. This hypothesis was tested in a double-blind trial conducted between April 2007 and February 2010 in 13 hospitals …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
